Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury.
about
Blue-Print Autophagy: Potential for Cancer TreatmentAcetaminophen-induced Liver Injury: from Animal Models to HumansXenobiotic and Endobiotic Mediated Interactions Between the Cytochrome P450 System and the Inflammatory Response in the LiverCurrent strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen speciesExperimental uterus transplantationLevosimendan: a cardiovascular drug to prevent liver ischemia-reperfusion injury?Experimental cryosurgery investigations in vivo.Icam-1 upregulation in ethanol-induced Fatty murine livers promotes injury and sinusoidal leukocyte adherence after transplantation.Treatment of liver ischemia-reperfusion injury by limiting thrombospondin-1/CD47 signaling.No evidence for protective erythropoietin alpha signalling in rat hepatocytes.Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretionAcute hyperglycemia worsens hepatic ischemia/reperfusion injury in rats.Small interfering RNA targeting heme oxygenase-1 (HO-1) reinforces liver apoptosis induced by ischemia-reperfusion injury in mice: HO-1 is necessary for cytoprotection.Nrf2 activation protects the liver from ischemia/reperfusion injury in miceLithocholic acid feeding results in direct hepato-toxicity independent of neutrophil function in miceSoluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis.Hydroxysafflor yellow A attenuates ischemia/reperfusion-induced liver injury by suppressing macrophage activation.The Impact of Sterile Inflammation in Acute Liver Injury.Mechanisms of pathogenesis in drug hepatotoxicity putting the stress on mitochondria.Reactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver.SPA0355 attenuates ischemia/reperfusion-induced liver injury in miceGenomics of liver transplant injury and regeneration.Activation of CD40 with platelet derived CD154 promotes reactive oxygen species dependent death of human hepatocytes during hypoxia and reoxygenationProgrammed death-1/B7-H1 negative costimulation protects mouse liver against ischemia and reperfusion injury.Conformational change in transfer RNA is an early indicator of acute cellular damageActivation of cyclic adenosine monophosphate-dependent protein kinase a signaling prevents liver ischemia/reperfusion injury in miceHepatocellular heme oxygenase-1: a potential mechanism of erythropoietin-mediated protection after liver ischemia-reperfusion injury.Impact of meriolins, a new class of cyclin-dependent kinase inhibitors, on malignant glioma proliferation and neo-angiogenesis.Biomarkers distinguish apoptotic and necrotic cell death during hepatic ischemia/reperfusion injury in mice.Fas mRNA expression and calcium influx change in H2O2-induced apoptotic hepatocytes in vitroHepatocyte apoptosis is enhanced after ischemia/reperfusion in the steatotic liver.Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosisSerum markers of hepatocyte death and apoptosis are non invasive biomarkers of severe fibrosis in patients with alcoholic liver disease.Lipopolysaccharide preconditioning protects hepatocytes from ischemia/reperfusion injury (IRI) through inhibiting ATF4-CHOP pathway in miceRecombinant adiponectin ameliorates liver ischemia reperfusion injury via activating the AMPK/eNOS pathwayCurrent issues with acetaminophen hepatotoxicity--a clinically relevant model to test the efficacy of natural products.Ischemic preconditioning induces autophagy and limits necrosis in human recipients of fatty liver grafts, decreasing the incidence of rejection episodes.Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis.Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice.N-acetylcysteine attenuates ischemia-reperfusion-induced apoptosis and autophagy in mouse liver via regulation of the ROS/JNK/Bcl-2 pathway.
P2860
Q26741800-C3EA4CAC-5AF4-405C-B545-215C11AF1C79Q26781944-F8F462AB-7AE2-4116-956D-279838869383Q26800213-25136E2D-0810-4892-A0D4-885DECB8DB98Q26849214-920DAB07-6AC0-4505-8A7D-6D409CD80815Q28264091-5E6DF131-CEF6-48EF-B49D-18495D882214Q28533304-D3578E17-FC1B-4829-BAA6-50C085C94EC0Q30478360-A33F05CB-9CA5-46C1-8FC7-7F54A933B9CCQ30518813-02525C57-48C0-4DAB-9D5A-17B7885074DAQ33392798-7C394896-B637-43F0-8356-DE1CA7F14042Q33433206-0952599B-2E45-4500-A0FB-0BE7D34BB430Q33604905-6CD2C278-75C1-4831-93AB-EEC58ED0CE42Q33647910-56229F3F-6D3F-418B-A336-AB6848C5ABBCQ33690996-AD857675-CD89-4F6C-9D46-631A65024ACAQ33717753-8EE3241A-F4D3-43E8-97A7-09A2E778B449Q33754301-4332811A-784A-4B9E-948D-3232549170DDQ33787691-8D0C8D2D-B746-4457-8029-825A145B4894Q33802791-48E9959A-4113-473E-A560-90B9340CC3A8Q33847610-F398DB1A-2AB6-47B9-AB25-679E30CABA9EQ33954265-FEAA3EC0-9B65-40C9-8DCC-64BEB11042F7Q34009236-47E64B0F-0CA5-49D4-9963-BDE96991414EQ34116246-7A1022E1-8126-43CF-AFEE-3FA1AA519F84Q34135578-2F3A12A0-531D-4944-A826-3B21B7646F5EQ34147716-AAC94389-FE09-4D2D-BB11-DDDB7A82992FQ34164098-1F6A89B5-7C77-4FDD-8047-15F2FEB34BD4Q34260059-AA9BD363-744A-4255-9076-5992CBEA9BADQ34292003-CFF2E639-0397-4F05-AFAD-39D91946B9B6Q34353139-A1FED4A8-1176-43B6-9824-4F02D94B0AADQ34359688-D9F541BD-F1E4-423F-83BB-6A0BF7939A8EQ34422178-D5DC870F-8C5E-47FE-832D-C329AB17E162Q34605785-F5B4A807-73CD-461A-9802-5D3F273BADC1Q34609691-F6A68C88-FA43-4371-B2F0-D5C26BF35157Q34655802-04D6E40B-160B-4005-BF5D-B7002877451DQ34698815-E66EBA2C-447F-4A08-800A-E50FB8DAA5C7Q34764338-DDBFE819-97B3-4250-B86D-038F1ECCAD15Q34770656-B175F662-825A-4F5F-8FB4-7F7CCA7D256AQ34792136-CA1DA4B1-52E7-4CE3-848E-783C5E09A359Q34797602-2966DAE3-D5F3-4B6D-8615-43127DCEA406Q34992341-8F0A7A90-8741-4C87-93BA-AD87F8592BEBQ35087943-83764D06-E87C-47A2-836B-4F9EB6B5532FQ35284048-88D5CD35-0BC1-4603-B2C4-0059D39AE529
P2860
Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury.
@ast
Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury.
@en
type
label
Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury.
@ast
Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury.
@en
prefLabel
Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury.
@ast
Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury.
@en
P1433
P1476
Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury.
@en
P2093
Hartmut Jaeschke
John J Lemasters
P304
P356
10.1016/S0016-5085(03)01209-5
P407
P577
2003-10-01T00:00:00Z